Partnering with GSK

Our collaborations

We believe the bigger the challenge, the bigger the need for collaboration. At GSK we have long been committed to partnering with the world's best minds and leading institutions and investing in our own capabilities.

0:30

Laboratory for Genomics Research

We created the Laboratory for Genomics Research with UCSF and UC Berkeley to advance genomic research and improve drug discovery.

09 January 2023

Partnerships that matter

How we engage

By collaborating with outstanding scientists at academic institutions to accelerate discovery and development of new vaccines and medicines
Through licensing advanced technology and potential vaccines and medicines from biotech companies
Establishing joint ventures to strengthen innovation and improve efficiency

Why this matters

Finding the right partner helps to identify and accelerate a potential vaccine or medicine to reach the patients that need it
It allows us to push the science and technology as far as it can go to impact human health
We can collectively share and advance our scientific knowledge

What we’re doing

Working with world-leading experts at biotech companies, research institutes and universities to improve drug and vaccine discovery to increase the productivity of our R&D pipeline
Collaborating with a broad range of partners to support our R&D focus on the science of the immune system, human genetics and advanced technologies
Supporting the advancement of scientific knowledge with our long-standing commitment to sharing research